ArticleAmerican journal of cancer research2025

Clinical outcomes of dabrafenib plus trametinib in locally advanced or metastatic BRAF V600E-mutant papillary thyroid cancer.

Yen-Hao Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.